Moderna COVID-19 Vaccine has obtained a final item license in Korea.

The MFDS announced on the 21st that GC Pharma has decided to permit imported items on the condition that it submits a final report on clinical trials for Moderna COVID-19 Vaccine, which it applied for permission for imported items on April 12.

Moderna COVID-19 Vaccine is an mRNA vaccine developed by Moderna in the United States that injects the COVID-19 antigen gene in the form of mRNA to synthesize antigen proteins in the body and neutralizes and removes viruses when COVID-19 invades the body.

The vaccine prevents COVID-19 at 18 years of age or older, after thawing, Moderna COVID-19 Vaccine 0.5 mL is add